Stock Options  The following table summarizes stock option activity for the year ended December 31, 2022 (in thousands, except per share amounts):  ##TABLE_START Options Outstanding Weighted-Average Exercise Price Per Share  Weighted-Average Remaining Contractual Life (years) Aggregate Intrinsic Value  Balance as of December 31, 2021 349,952 &#160; $ 7.81 &#160; 9.06 $ 3,638,685 &#160; Options exercised ( 19,660 ) 4.38 &#160; Options canceled and forfeited ( 3,379 ) 4.95 &#160; Balance as of December 31, 2022 326,913 &#160; $ 8.05 &#160; 8.33 $ 272,603 &#160; Options vested and exercisable as of December 31, 2022 183,119 &#160; $ 5.77 &#160; 7.43 $ 257,113 &#160; ##TABLE_END The aggregate intrinsic value of options outstanding, and vested and exercisable is calculated as the difference between the exercise price of the underlying options and the fair value of the Company&#8217;s common stock as of December 31, 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2022, 2021, and 2020 was $ 112.3 million, $ 3.8 billion, and $ 974.2 million, respectively, and is calculated based on the difference between the exercise price and the fair value of the Company&#8217;s common stock on the exercise date.  There were no options granted during the year ended December 31, 2022 and 2021. The weighted average grant-date fair value of options granted during the year ended December 31 2020 was $ 2.57 per share. The total grant-date fair value of options that vested during the years ended December 31, 2022, 2021, and 2020 was $ 170.8 million, $ 189.5 million, and $ 214.7 million, respectively .  As of December 31, 2022, the total unrecognized stock-based compensation expense related to options outstanding was $ 721.9 million, which is expected to be recognized over a weighted-average service period of eight years .  Palantir Technologies Inc.  Notes to Consolidated Financial Statements (continued)  Determination of Stock Option Fair Value  The estimated grant-date fair value of all the Company&#8217;s stock-based option awards was calculated using the Black-Scholes option-pricing model, based on the below assumptions. There were no options granted during the years ended December 31, 2022 and 2021.  ##TABLE_START Year Ended December 31, 2020 Fair value of common stock $ 7.60 &#160; Expected volatility 71.00 &#160; % Expected term (in years) 12.04 Expected dividend yield &#8212; &#160; % Risk-free interest rate 0.64 &#160; % ##TABLE_END  RSUs  The following table summarizes the RSU activity for the year ended December 31, 2022 (in thousands, except per share amounts):  ##TABLE_START RSUs Outstanding Weighted Average Grant Date Fair Value per Share RSUs unvested and outstanding as of December 31, 2021 153,749 &#160; $ 9.56 &#160; RSUs granted 33,673 &#160; 10.24 &#160; RSUs vested and converted to shares ( 51,941 ) 8.73 &#160; RSUs canceled ( 9,055 ) 9.78 &#160; RSUs unvested and outstanding as of December 31, 2022 126,426 &#160; $ 10.07 &#160; ##TABLE_END Prior to September 30, 2020, the Company granted RSUs with both a service-based vesting condition and a liquidity event-related performance condition which was considered a performance-based vesting condition. The stock-based compensation expense related to such RSUs is recognized using the accelerated attribution method from the grant date. The service-based vesting period for these awards varies across service providers and is up to five years . The performance-based vesting condition for the RSUs was satisfied upon the Company&#8217;s Direct Listing, which occurred on September 30, 2020. Additionally, subsequent to September 30, 2020, the Company granted RSUs with only a service based-based vesting condition. The stock-based compensation expense related to such RSUs is recognized ratably over the service period.  During the year ended December 31, 2020, the Company recognized $ 940.0 million in stock-based compensation expense related to RSUs, of which $ 769.5 million was recognized upon the Company's Direct Listing which satisfied the performance-based vesting condition.  The total grant-date fair value of RSUs vested during the years ended December 31, 2022, 2021, and 2020 was $ 453.2 million, $ 421.0 million, and $ 531.9 million. As of December 31, 2022, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $ 770.3 million, which is expected to be recognized over a weighted-average service period of three years .  Palantir Technologies Inc.  Notes to Consolidated Financial Statements (continued)  Stock-based Compensation Expense  Total stock-based compensation expense was as follows (in thousands):  ##TABLE_START Years Ended December 31, 2022 2021 2020 Cost of revenue $ 44,061 &#160; $ 68,546 &#160; $ 139,627 &#160; Sales and marketing 196,301 &#160; 242,910 &#160; 398,205 &#160; Research and development 93,871 &#160; 150,298 &#160; 357,063 &#160; General and administrative 230,565 &#160; 316,461 &#160; 375,807 &#160; Total stock-based compensation expense $ 564,798 &#160; $ 778,215 &#160; $ 1,270,702 &#160; ##TABLE_END The Company did not recognize any tax benefits related to stock-based compensation expense during the years ended December 31, 2022 or 2021, and it recognized tax benefits of $ 18.2 million during the year ended December 31, 2020.  11. Income Taxes  Loss before provision for (benefit from) income taxes consisted of the following (in thousands):  ##TABLE_START Years Ended December 31, 2022 2021 2020 United States $ ( 402,834 ) $ ( 514,200 ) $ ( 1,203,682 ) Foreign 41,807 &#160; 25,706 &#160; 24,655 &#160; Loss before provision for (benefit from) income taxes $ ( 361,027 ) $ ( 488,494 ) $ ( 1,179,027 ) ##TABLE_END Provision for (benefit from) income taxes consisted of the following (in thousands):  ##TABLE_START Years Ended December 31, 2022 2021 2020 Current: Federal $ &#8212; &#160; $ &#8212; &#160; $ &#8212; &#160; State 765 &#160; ( 88 ) 500 &#160; Foreign 9,476 &#160; ( 11,343 ) 7,249 &#160; Total current provision 10,241 &#160; ( 11,431 ) 7,749 &#160; Deferred: Federal &#8212; &#160; ( 111 ) &#8212; &#160; State &#8212; &#160; &#8212; &#160; &#8212; &#160; Foreign ( 174 ) 43,427 &#160; ( 20,385 ) Total deferred provision ( 174 ) 43,316 &#160; ( 20,385 ) Total provision for (benefit from) income taxes $ 10,067 &#160; $ 31,885 &#160; $ ( 12,636 ) ##TABLE_END Palantir Technologies Inc.  Notes to Consolidated Financial Statements (continued)  A reconciliation of the expected tax provision (benefit) at the statutory federal income tax rate to the Company&#8217;s recorded tax provision (benefit) consisted of the following (in thousands):  ##TABLE_START Years Ended December 31, 2022 2021 2020 Expected tax (benefit) at U.S. federal statutory rate $ ( 75,592 ) $ ( 102,584 ) $ ( 247,596 ) State income taxes - net of federal benefit 766 &#160; ( 88 ) 500 &#160; Foreign tax rate differential 832 &#160; 870 &#160; ( 4,131 ) Research and development tax credits ( 34,546 ) ( 94,591 ) ( 26,294 ) Stock-based compensation 1,374 &#160; ( 817,839 ) ( 194,730 )  Non-deductible officers&#8217; compensation  40,629 &#160; 428,682 &#160; 76,093 &#160; Change in valuation allowance 49,833 &#160; 616,572 &#160; 373,632 &#160; Base Erosion Anti-Abuse Tax and related elections 25,200 &#160; &#8212; &#160; &#8212; &#160; Other 1,571 &#160; 863 &#160; 9,890 &#160; Total provision for (benefit from) income taxes $ 10,067 &#160; $ 31,885 &#160; $ ( 12,636 ) ##TABLE_END For the year ended December 31, 2022, the Company recorded a provision for income taxes of $ 10.1 million compared to $ 31.9 million for the year ended December 31, 2021, primarily due to the prior year establishment of a full valuation allowance against its U.K. deferred tax assets during the fourth quarter of 2021 partially offset by permanent differences associated with U.S. Base Erosion and Anti Abuse Tax elections. The Company maintains a full valuation allowance against its U.S. federal and state and U.K. deferred tax assets.  For the year ended December 31, 2021, the Company recorded a provision for income taxes compared to a benefit from income taxes for the year ended December 31, 2020, primarily due to the establishment of a full valuation allowance against its U.K. deferred tax assets during the fourth quarter of 2021, partially offset by a one-time benefit related to the refund of the Company&#8217;s U.K. 2019 taxes paid based on the tax election to carry back the 2020 U.K. net tax operating losses.  Deferred tax assets and liabilities are recognized for the future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax basis using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant deferred tax assets and liabilities consisted of the following (in thousands):  ##TABLE_START As of December 31, 2022 2021 Net operating loss carryforwards $ 1,436,957 &#160; $ 1,497,774 &#160; Capitalized research and experimental expenses 70,839 &#160; &#8212; &#160; Reserves and accruals 76,905 &#160; 43,348 &#160; Tax credit carryforwards 226,565 &#160; 177,402 &#160; Stock-based compensation 203,735 &#160; 212,163 &#160; Lease liabilities 58,056 &#160; 59,787 &#160; Depreciation and amortization 29,665 &#160; 35,176 &#160; Gross deferred tax assets 2,102,722 &#160; 2,025,650 &#160; Outside basis difference ( 6,512 ) &#8212; &#160; Acquisition related intangibles ( 10,225 ) &#8212; &#160; Right-of-use assets ( 46,295 ) ( 49,665 ) Total net deferred tax assets before valuation allowance 2,039,690 &#160; 1,975,985 &#160; Valuation allowance ( 2,051,655 ) ( 1,977,565 ) Net deferred tax assets $ ( 11,965 ) $ ( 1,580 ) ##TABLE_END 